How is the Quince Therapeutics Inc today?

The Quince Therapeutics Inc today is trading in the down by -0.94% at 1.05.

How has Quince Therapeutics Inc performed historically?

The Quince Therapeutics Inc is currently trading down -0.94% on an intraday basis in the past week the index fell -5.41%. The index has been down -27.59% in the past quarter and rose 26.51% in the past year. You can view this in the overview section.

What is Quince Therapeutics Inc Annual Net Profit?

Quince Therapeutics Inc Annual Net Profit fell 81.07% in the last year to $56.83 M. Its sector's average net profit growth for the last fiscal year was -13.88%.

What is Quince Therapeutics Inc Price to Earning Ratio?

Quince Therapeutics Inc Price to Earning Ratio is -0.79, which is negative.

What is Quince Therapeutics Inc Stock Price?

Quince Therapeutics Inc Stock Price rose 26.51% and underperformed its sector by 0.03% in the past year.

What is Quince Therapeutics Inc Quarterly Net profit?

Quince Therapeutics Inc Quarterly Net profit fell 34.81% YoY to $15.03 M. Its sector's average net profit growth YoY for the quarter was -238.37%.

What is Quince Therapeutics Inc Debt to Equity Ratio?

Quince Therapeutics Inc Debt to Equity Ratio of 0.49 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Quince Therapeutics Inc Return on Equity(ROE)?

Quince Therapeutics Inc Return on Equity(ROE) for the last financial year was -98.63%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Quince Therapeutics Inc Mutual Fund Holding?

Quince Therapeutics Inc Mutual Fund Holding increased by 0.2% in the last quarter to 7.54.

What is Quince Therapeutics Inc Promoter Share Holding?

Quince Therapeutics Inc Promoter Share Holding stayed the same in the most recent quarter at 5.68%.

What is Quince Therapeutics Inc Institutional Holding?

Quince Therapeutics Inc Institutional Holding increased by 2.01% in the last quarter to 13.64.

Quince Therapeutics Inc XNAS: QNCX

Quince Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Quince Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Quince Therapeutics Inc
Rating: 1.13558325
Author: Trendlyne DVM scores

about

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small mol...

1.05 -0.01 (-0.94%)

57.14% Fall from 52W High

67,718 XNAS Volume

XNAS 03 Jun, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Quince Therapeutics Inc is on 05 Jun 2025 for the purpose of Quince Therapeutics Inc Annual General Meeting for 2025 See details

Not Eligible

Expensive Valuation

9.3 / 100

Technically Neutral

36.1 / 100

No estimates available

Quince Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Quince Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small mol...

57.14% Fall from 52W High

SWOT Analysis

Quince Therapeutics Inc Live Price Chart

Quince Therapeutics Inc FAQ

How is Quince Therapeutics Inc today?

Quince Therapeutics Inc today is trading in the red, and is down by -0.94% at 1.05.

How has Quince Therapeutics Inc performed historically?

Quince Therapeutics Inc is currently trading down -0.94% on an intraday basis. In the past week the stock fell -5.41%. stock has been down -27.59% in the past quarter and rose 26.51% in the past year. You can view this in the overview section.